Swedish Orphan Biovitrum AB
SOBI:OMX
As a specialised international biopharmaceutical company, Swedish Orphan Biovitrum provides sustainable access to innovative therapies in the areas of haematology, immunology and specialty care.
© 2024 Streetwise Reports. All rights reserved.
Streetwise Reports is registered with the U.S. Patent and Trademark Office.
